|
|
Perseus Proteomics Inc
TSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/25/2026 15:30
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSE
Market Capitalization2,447.93 mln
Float16.60 mln
Earnings Date08/18/2025
Key Fundamentals
EPS-48.17
ROE-58.17
RPS8.52
ROIC-995
ROA-43.93
EBITDA, mln-745
EV / EBITDA-1.44
EV / EBIT-1.43
Revenue, mln136
EV / Revenue7.89
Financial Strength
Altman Z-Score2.98
Piotroski F-Score
5
/ 9
Beneish M-Score-2.92
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
12.58% |
98
/ 100
 |
| 1 Month |
3.66% |
79
/ 100
 |
| 2 Months |
-32.81% |
4
/ 100
 |
| 6 Months |
-39.07% |
3
/ 100
|
| 1 Year |
-58.74% |
2
/ 100
|
|
| |
